Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001102598-23-000009
Filing Date
2023-02-10
Accepted
2023-02-10 16:49:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sanofi12312022.htm SC 13G/A 15760
  Complete submission text file 0001102598-23-000009.txt   17646
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Subject) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-60069 | Film No.: 23612912
SIC: 2834 Pharmaceutical Preparations

Mailing Address 91-93 BOULEVARD PASTEUR PARIS I0 75015
Business Address 91-93 BOULEVARD PASTEUR PARIS I0 75015 33 1 43 23 30 30
Amundi (Filed by) CIK: 0001330387 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13G/A